<DOC>
	<DOCNO>NCT00204347</DOCNO>
	<brief_summary>The objective Study A evaluate efficacy risperidone 4 behavioral dimension Berderline Personality Disorder ( BPD ) open label trial : mood swing , impulsivity , thing difficulty disturb relationship . The secondary objective study ( Study B ) validate self-report measure clinical symptom specific treatment patient BPD , UAB Borderline Rating Scale ( BRS ) .</brief_summary>
	<brief_title>Effective Measurement Risperidone Treatment Outcome Persons With Borderline Personality Disorder</brief_title>
	<detailed_description>Study A : An open-label , prospective trial efficacy safety risperidone treatment BPD.The study 8 week duration , screen visit follow-up visit end Weeks 1,2,3,4,6 , 8 . 20 female patient , 19 year older recruit . A full medical psychiatric history take physical exam perform sstudy physician . A psychosocial assessment conduct screen . Study B : The ofjective validate UAB BRS administer BRS neuropsychological instrument repeat measure 6 week period 40 patient BPD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis BPD Any Axis I diagnosis except dysthymia , PTSD , generalize anxiety disorder ; substance abuse within month ; unstable medical illness .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>risperidone</keyword>
</DOC>